What is the real role of corporate venture capital?
Lantz, Jean-Sebastien ; Sahut, Jean-Michel ; Teulon, Frederic 等
I. INTRODUCTION
Issues related to innovation are crucial because the latter allows
companies to establish or strengthen their competitive advantages by
differentiating themselves from their competitors and gaining market
share. It can be defined as "any process allowing to extract
economic benefits or social knowledge constituted through the
development and realization of ideas which improve products, services or
process" (Source: Fund for Innovation, Canadian Innovation and
Projects Section). Innovation is thus the core of the firms'
competitive strategies. It is the source of most century firms and a key
factor of economic growth in many countries. In most countries, it is
widely approved that the most intensive firms in information and
communication technologies (ICT) are also those which innovate more
frequently and combine several types of innovation. With the rapid
development of ICT since the 1980s, many dynamic small companies have
performed a fundamental role for innovation in high tech sector. Then,
large enterprises questioned their expensive R&D programs and
decided to invest in innovative firms, either directly or through
private equity funds. This type of investment, called corporate venture
capital (CVC), is not only a means to make profits, but more
importantly, a highly strategic way to maintain a control of innovation
by acquiring the latest innovations when they start developing. Despite
crises, CVC continues to grow in the high-tech sectors, particularly in
biotechnology. The advantages it brings at every stage of the project as
opposed to financing by venture capital funds will be key factors for
its future development. In order to gain a better understanding of the
role of CVCs in the financing of innovating firms, we propose in this
article to analyze the various types of CVC on the basis of former
studies as well as concrete examples, then to assess what boosts value
creation for CVC projects.
II. CHARACTERISTICS OF CORPORATE VENTURE CAPITAL
A. Definition of Corporate Venture Capital
In strategy, two types of technological alliances exist:
cooperation agreements and capital participation. If the first type is
based on a short or medium-term partnership, aiming at sharing certain
strategic resources in particular in terms of R&D, the second type
of strategic alliance leads to an exchange of capital and thus to strong
commitments from each partner.
Along with joint-ventures and partial mergers, corporate venture
capital (CVC) today has become one of the most widespread forms of
financing for new innovating firms. In fact, CVC is only another form of
venture capital. The concept is not recent and first made an appearance
at the end of the thirties in the United States. It developed gradually
to become a branch of finance specialized in funding innovative SMEs
with strong growth potential.
The role of "corporate venture capital" funds, also named
"industrial venture capital funds", is for a parent company to
contribute capital equity complemented by industrial input to an
innovative start-up through an investment fund dedicated to industrial
innovation.
This type of fund excludes any entity with a purely financial
company as lead investor. The main difference between corporate venture
capital and venture capital is the nature of the utility of fund
partners.
Contrary to a traditional venture capital firm which seldom
intervenes in the day-to-day running or decision making process of the
firm it finances, CVC goes much further than simple leveraging.
The incentive for industrial groups to get involved in CVC can be
summarized according to the five following points:
* Technological interest: by investing in highly innovative firms
in the same line of business, industrial groups can track innovations
closely while keeping a lid on its R&D expenditure. In this way
corporations can guard against these firms making technological
breakthroughs by signing agreements for developing joint projects,
license transfer or the acquisition of the firm at a later date
(integrating the target company into the group) as from the first input
of funds,
* Adding value to in-house R&D: by supporting the creation of a
start-up by spinoff, corporations develop their patent portfolio, the
majority of which are often unexploited, via licensing agreements,
* Market tracking and the experience effect: financing start-ups in
new markets provides investors with information on customer behaviour
vis-a-vis new products/services which could be used to develop new
products/services inside the group,
* Implementing new practice: the start-ups in which the groups
invest can be used as a laboratory to test new practices of external
management (vis-a-vis customers or suppliers) or internal (between
employees, between management and staff) which could be adopted by the
group if successful,
* Financial interest: last but not least there is the financial
aspect. As for other venture capital investments, the corporations hope
to have made a capital gain on their investment at the time of exit or a
return through dividend payments.
In this context, there are two ways of viewing the concept of
Corporate Venture Capital; as external risk taking for the firm or as an
alternative source of financing innovative start-ups (Gompers &
Lerner, 2000). These two conceptions of CVC are not contradictory. Quite
the reverse is true. They show common interests shared through an
organisational mode which ensures the outsourcing of risk while enabling
the financing and control of innovative projects. This is why CVC is
often initially defined (Muzyka et al., 1996) as an input of capital
equity and technical or strategic expertise to start-up entrepreneurs.
This highlights the relationship of dependence that the start-up has
from the parent company.
This relationship of dependence is conditional on the control
exerted by the parent company on the investment fund and one can thus
distinguish two categories of CVC:
Semi-captive funds are created and capitalized by a large company
which keeps control of it. The funds may be open to other industrial
partners. The strategic objective of these funds is to invest primarily
in projects close to the core activity of the original investors. This
is the case for Innovacom, Emertec, Chrysalead, etc.
-Captive funds are wholly owned by the parent company and their
goal is to serve the strategic and financial interests of the latter.
This is the case for Unilever Technology Venture, France Telecom
Technologies Investments (FTTI), Intel Capital, etc.
Thus, contrary to management firms specialized in venture capital,
CVC has a strategic approach which is primarily industrial. These funds
seek to invest in projects which have synergies with the
corporation's own businesses.
However, the organisational changes resulting from the
implementation of Corporate Venture Capital programs are not always
positive, hence the many detractors. The drawbacks include:
-Firstly, preserving integrity towards projects which are in
competition with those of the parent company.
-Secondly, yielding to the economic climate and the strategic
choices of their chief executives. The capital often comes from the
surplus liquidity of the parent company. Their existence is therefore
called into question during an economic downturn. There is no lack of
examples; Innovacom (France Telecom) and Viventures (Vivendi) are today
independent. Valeo Venture was closed down by the new CEO who considered
that the program was of 'little strategic interest', whereas
Air Liquide Ventures was taken over by Alto Invest for the same reasons
...
To be successful, the financial intermediation in CVC should
restore the dominant role of financial activism by including the
processual dimension of investment and investment withdrawal. By
investing in projects, the CVC acquires information whose value is
maximized if the transaction costs of project identification, selection,
investment, follow-on support and withdrawal are lower than those which
would be generated by direct investments. Consequently, the
intermediation in CVC is only relevant to new ventures whose specificity
is not only to be innovating, but also to offer something outside the
firm' s expertise. In other words, the CVC justifies its role if:
-financial undertakings are targeted at innovative start-ups whose
information is not transparent (firms with asymmetric information),
-the need for a device to indicate the quality of targeted projects
is vital to avoid multiplying direct investments in innovative projects
a large proportion of which could turn out to be unsuccessful or not
strategic.
B. Importance of CVC Funds in Technological Sectors
After the record years of the Internet bubble, the CVC share in
total venture capital resumed its earlier level before the bubble, which
was approximately 7% in 2009. This atypical period of investment is
engendered mainly by the large firms of the ICT sector which invested in
start-ups in order to benefit from their innovations. For example, Intel
invested in 1998 in the Red Hat because it considered its free software
as complementary to its own offer. Today, large companies face an
inconsequential threat of new technologies emergence which are able to
modify their markets rather than during the Internet bubble. This is why
their investments in start-ups decreased to reach the same level as 1997
(figure 1). It results that the majority of large companies do not carry
out important investments in start-ups because they do not consider
these investments as a crucial strategy to cope with technological
change.
This observation seems astonishing because on many markets, true
technological splits came from start-ups. As an Internet provider in
France and thanks to its technological advance, Free, with its
"adsl box" became the real competitor to France Telecom, the
historical operator of telecommunication on the French market. Thus,
investment in start-ups, which makes current technologies and economic
models of established firms obsolete, seems a good means for these
companies to maintain a dominant position on the market.
But CVC funds have a major disadvantage compared to independent
venture capital funds. They have to invest, keeping in mind the strategy
of their parent company, which makes it difficult to make bets on really
revolutionary start-ups. This also means to support a firm which aims at
destroying their parent company.
[FIGURE 1 OMITTED]
Our study carried out in 2008 (see Table 1), on a sample of the 142
largest market capitalizations of American and European technology-based
companies, show that 40% of the European groups have funds dedicated to
Corporate Venture Capital against 60% for the American groups. The size
of the CVC funds ranges from 21 million dollars for SBC Communication to
4 billion dollars for INTEL. The median size of the funds is largely
equivalent in the United States (140 million dollars) and in Europe (120
million euros). The CVC funds are notably present in high-tech sectors
since more than three quarters of industry groups in the sample have CVC
funds. However, traditional business sectors characterized by a high
proportion of tangible assets, tangible products and long business
cycles have far fewer CVC funds.
These results are consistent with the 2010 PwC/NVCA MoneyTree
Report and show the evolution in industry sector of investment. In 1998
the top sector, respectively for venture capital and corporate venture
capital investment, were software and telecommunications for the first
one, software, telecommunications, networking and media for CVC
investments. In 2008, the biotechnology and medical devices sectors
became two predominant targets of investment for venture capital and
CVC. The last figures of NVCA (1) highlight a significant increase in
2010 of Clean Technology sector with $3.7 billion invested in 267 deals.
This investment level exhibits a 76% increase in dollars and a 37%
increase in deal volume from 2009 when $2.1 billion went into 195 deals.
The CVC Investment represents 17% of the deals and 15% of the
investments in this sector.
C. Typology of Corporate Venture Capital
Concerning CVC, several typologies have been put forward in
academic literature (Ben Haj Youssef, 2001) which we summarize in Table
3. This typology is based on concrete examples of CVC programs set up by
multinational firms or large corporations recognized in their respective
sectors as being leading stakeholders in innovating activities and in R
& D.
The creation of an internal division which deals exclusively with
investment in innovating firms first appeared in the Seventies (1.1).
During this period, 25% of the 500 biggest firms listed by Fortune in
the United States created such divisions. For example, GE Business
Development Services was for a long time the body which tracked
high-tech and investments for General Electric. However, other firms
preferred to invest in internal funds (1.2). This is the case of Texas
Instruments, Apple and AT&T in the United States and Nokia in
Sweden. In France, several large groups followed this trend such as the
Innovacom fund (198 million euros, France Telecom). Compared to the
first type, internal investment funds spare the firm any shortcomings of
the internal division concerning problems of coordination and
organisational control (reticence by executives, company culture,
administrative complexity, etc). In other words, operationally, the firm
recruits a team of venture capital specialists which is put in charge of
managing the funds and keeps a level of autonomy.
Other forms of direct CVC now exist. For example, the executives of
the parent company may successfully develop new products which result in
the creation of a new firm. The parent company gives support by creating
a spin-off fund (1.3) such as Technocom Ventures created by France
Telecom in partnership with Newbridge Networks. Other partnerships
between a large and a small company focus on financing a specific
project whose development will benefits both parties. This is the case
of the venture-cooperation (1.4) between Johnson & Johnson, the
American chemicals and pharmaceutical giant, and Damon, an innovating
firm, to develop hospital equipment. The last type of direct CVC is
'step-by-step' investment (1.5). Examples of this type of
investment are marginal because it enables a corporation to participate
in projects which neither bring in high returns, because the firm has a
minority investment stake, nor does it allows control of innovations
from the target firm, but simply affirms its presence and its brand
image in its business sector.
Lastly, it should be noted that the mode of financing through
external investment funds, managed by venture capital firms, remains
highly attractive. Indeed, direct CVC only represents about a sixth of
the overall annual sum invested in innovating firms in the United
States. The success of the indirect method is due to the low commitment
required and the flexibility in the choice of a portfolio of companies
to be financed. This makes it possible to spread risk while increasing
the amount of participation. It is true that indirect CVC does not allow
for tracking technological advances but this monitoring is very costly:
out of ten projects financed by a direct CVC, only one to two projects
are successful and nearly half are failures (Lachmann, 2001).
III. DRIVERS OF VALUE CREATION FOR CVC PROJECTS
While the goal of an independent VC is looking for performance, a
CVC fund must balance strategic objectives from its parent company and
financial goals. These objectives can be conflicting and create agency
conflicts between financed firms and the CVC fund. It is therefore
necessary to analyze the goals of CVC funds in order to understand their
influence on value creation of companies they fund.
A. Objectives of CVC and Benefits for Star-up
Generally, a CVC fund has a strategic mission to improve
competitiveness and consequently the turnover of its parent company. As
for their mode of intervention, almost all funds privilege direct
investments (90% of funds), and 60% of CVC funds made limited partners
investment (NVCA, 2010).
Our study shows that almost 70% of CVC investors have a combination
of strategic and financial objectives: 15% invest only for strategic
value and 16% only for financial return. Moreover, even if 50% invest
primarily for strategic value, financial return is a requirement. On the
same way, for the 19% of CVC funds, which invest primarily for financial
return, look for synergies with the target.
Following the results presented in table n[degrees]4, the main
strategic reasons cited by the managers of CVC funds are mainly the
access to new markets (92%) and the development of products (88%) or
technologies (83%). These results are consistent with previous studies
which identify three principal strategic motives for this type of
investment: gain "window" on emerging technologies (Dushnitsky
and Lenox, 2005), facilitate development of firms offering complementary
products or services (Chesbrough, 2000), and identify and monitor
potential acquisition targets (Maula and Murray, 2001).
For big firms (BF), carrying out this type of investment permits
them:
-To accelerate their process of training: CVC avoid big costs of
R&D programs by multiplying and diversifying projects and
investments. The CVC supports investments in start-ups (and financial
risk involved) while its parent office (BF) can benefit from the
innovations accomplished by start-ups,
-To increase the effectiveness of technological watch. The
objective is to identify the emerging markets as well as uses of
customers and potential applications (Maruca, 1999), to create a
complete system of offer with some partner customers, and to detect
relational or processual innovations which, if they prove to be
effective, will be adopted by the parent company. These techniques make
it possible to precede innovation for on the one hand, not to be
outdistanced on markets in the midst of technological changes and, on
the other hand, to avoid developing similar in-house projects that are
perfectly carried out outside (this resulting in clearly reducing
in-house human costs and increasing the R&D on the key activities of
the parent company,
-To have a new means of action. Indeed, the CVC offers the BF the
possibility of managing the innovation in "acting to
understand" (Jumel, 2004). The objective is to act first, to invest
in a start-up, to launch a product or service by keeping the necessary
flexibility to go back once the BF tests the utility of innovation. It
is the opposing view to the traditional R&D approach.
To evaluate the influence of the CVC financing on start-up targets,
it is necessary to bring compare the CVC's objectives to the
benefits which they bring from a strategic point of view.
The study by McNally (1997) is one of the only ones covering the
benefits CVC has brought to different ventures created in the United
Kingdom. In the firms studied there are 23 start-ups (see Table 5). It
shows that CVC funds played a more important role than the other funds
involved. According to McNally, the most significant advantages are an
increased credibility, help with short-term problems and access to
organisational management know-how. This study also suggests that
contacts between a start-up and its CVC are more frequent than with an
investor in Venture Capital. More generally, the advantages of CVC in
the eyes of the entrepreneurs are detailed in the table below.
In the same way, Hellman's analysis (2001) on CVC investments
highlights complementarities between the startup and the parent company
as being the key factor of success. This author stresses that startups
which maintain the business relationship (in addition to strictly
financial relations) with the corporation statistically form more
alliances with other firms. As an example, one can quote the case of
Fon.Com, a company from Madrid having raised 18 million euros in the
first pool at the beginning of February 2006. This start-up gets its
strength from its prestigious industrial shareholders such as Google and
Skype and from big venture capitalists like Sequoia Capital (US) and
Index Venture (Swiss) who backed the project.
Another advantage for the start-up financed by CVC is to integrate
a network of entrepreneurial relationships. In their model of growth per
start-up stage, Kazanjian and Drazin (1989) explain how this sort of
network develops. At its creation, the network is limited to the private
bonds maintained by the director with other people. They are mainly
family members and friends of the entrepreneurs who provide the first
essential resources to the early stage of the start-up.
Then, when the firm enters a phase of expansion, it is the need for
finance, expertise, market knowledge and know-how which guide the search
for partners. The start-up then examines the cost and the benefits of
any commitment to a relation with a partner. One can summarize these
factors of finding partners under three categories:
-access to resources: these resources can be financial (one
therefore contacts a venture capitalist) or may be the access to
distribution networks, production infrastructures or any other resources
which are necessary to create, produce and distribute ones products in a
competitive way.
-access to knowledge: the start-up needs to optimize its resources
in order to obtain the best result. Developing its expertise and its
organization present a challenge which needs to be overcome. In the
search for an investor, being able to benefit from strategic advice can
prove decisive. This knowledge can be more practical such as the
acquisition of a technology.
-the advantage of image: legitimacy is an important factor and
association with one of the main players in the sector improves the
company's image with customers. The choice of partner also affects
the choice of the venture capitalist: it is preferable to find a reputed
one who will be able to give a stamp of quality to the firm in which he
invests.
B. Performances of Start-ups Financed by CVC
Venture capital investors have an important role in mediating the
investment of a startup company. The performance of this particular
investment has been the core subject in several recent studies but the
performance of corporate venture capital is not so well documented.
Most studies in the literature focus on venture capital in general
such Block and MacMillan (1993), Ljungqvist and Richardson (2003), and
Kaplan and Schoar (2005).
In the last studies, Ljungqvist and Richardson (2003) analyze the
process of investment from the perspective of the GP by concentrating
the study on the sums invested versus sums distributed. They find that
Private Equity funds perform better than the market. However their
sample is relatively small. Moreover, they have left out venture capital
funds from their sample which generally has an average performance which
is much lower than Private Equity funds. The study by Kaplan and Schoar
(2005) is considered the leading article on the subject. The authors try
to assess the net return investors receive over the fund's
lifespan. The authors use a broad sample of mature American funds, set
up during the period 1980-1997. The data comes from Venture Economics
and covers 746 funds operating in the venture capital (VC) and buyout
(BO) segments, which have an identified GP. Kaplan and Schoar (2005)
show that in the United States, the average net profitability of Private
Equity funds is 5% higher than the average profitability of the S&P
500 index over the period 1980-2001. The profitability of these Private
Equity funds is calculated after fund managers have been compensated
(approximately 20% of carried interest and 1.5% to 2.5% of the managed
funds in management fees), which shows a brut performance well above
that of funds invested in listed shares.
Taking into account the duration of investment, that means the ROI
difference in annual terms between venture capital and public equity is
certainly positive but weak. This result is rather surprising when
taking into account the specific features of the private equity asset:
risks linked to the agency relationship between LPs and GP, the nature
and risk of the projects funded, the level of debt leverage/equities of
BO transactions and the illiquidity of the investment. This small yield
gap contradicts the often more flattering level of returns announced by
the media or the industry.
Artus (2008) analyzes the comparative returns of private and the
public equity on the US and European markets, over the periods 1995-2006
and 1996-2006 respectively. Using a different method from Kaplan and
Schoar the aggregated returns from private equity are calculated quarter
after quarter taking into account the balance of cash-flows during the
period and the differences in net asset value (NAV) of the funds between
the beginning and the end of the period. The evaluation of the NAVs,
reported by the funds, is an approximate accounting procedure, which
could be thought to "smooth" changes to the true fund value.
With this method, the net yield gap in favour of private equity over
listed assets reaches 6.99% per year in the United States and 8.29% per
year in Europe. Taking into account the volatilities and correlation
between the returns of the two categories of assets, Artus (2008)
estimates that the level of private equity held by investors is below
the optimal level resulting from a model of portfolio choice.
Corporate Venture Capital (CVC) is significantly different from
traditional venture capital in organizational structure, objectives,
investment behavior, and the service range offered to portfolio
companies (Gompers and Lerner, 2000). These differences may engender
important implications for the CVC performance and the results have to
be analyzed very carefully because of the bias in the measure of
performance. For example, Porter (1987) studied various investments
(joint ventures and start-up) of 33 major groups between 1950 and 1986.
He merely argued that "the disparities between investments are
enormous" and do not allow to make any statistical comparison.
For some authors, the performance is similar for the two sorts of
investment. Gompers and Lerner (2000) consider that the performance of
CVC is similar to that of independent VCs at an equal risk level and on
the same industries and activities. This performance was calculated for
30 000 investments during 1983-1994 on two criteria: the probability of
achieving an IPO or being acquired for more than twice the value of the
initial investment.
This similarity is observed particularly in cases where the
strategic objective of CVC is clearly identified. However, when
investments are made without a strong strategic reason, they appear less
stable than those of independent VCs (id est that some investment may be
stopped prematurely because of the bankruptcy target).
A second category of authors considers that CVC offers a better
performance than independent VC. In their meta-analysis based on eight
major studies on the subject, involving about 200 companies, Block and
MacMillan (1993) highlight that seven studies show that CVC activities
have reached a better performance than traditional activities.
Stuart et al. (1999) and Chesbrough (2000) note a higher valuation
of CVC-backed IPOs as opposed to exclusively traditional VC-backed
firms. Moreover, the paper of Stuart et al. (1999) based on the analysis
of 301 venture-backed biotechnology firms between 1978 and 1991,
highlights that strat-ups financed by CVC are introduced on the stock
market more quickly (Ginsberg et al, 2003; Maula and Murray, 2001).
Ivanov and Xie (2010) confirm the existence of additional value for
CVC-backed startups at IPOs. They also point out that CVC-backed firms
are better valued at acquisitions when they observe a strategic relation
between CVC objectives and the target.
Academics and practitioners have long suggested that CVCs add value
to their portfolio firms, but evidence to such a problem is rather
limited. Some previous studies find that CVC-backed startups investment
is mainly fostered by a double purpose: financial objectives and
strategic objectives. Financial objectives were mentioned in several
studies and they were also considered as an important feature of CVCs.
This is because return is among the most current performance indicators
for companies.
Actually, CVCs can select the most profitable companies which
suggest a markedly better performance. In addition, CVCs may provide
expertise and backing, which can be of great benefit to firms thanks to
specialized staff who is well informed about the market and Information
Technology. Thus, CVCs may be able to provide their portfolio startup
companies with a rapid access to markets, technical help, and an inside
knowledge of the product, given their collaboration with trade
industries. Therefore, CVCs act an important role in distribution and
research and development (Teece, 1986; Stuart et al., 1999; Gompers and
Lerner, 2000; Maula and Murray, 2001). Such a CVC-backing paves the way
for the success of a start-up and consequently, it results in a higher
financial performance.
The discrepancy in the considered CVC shows that complementarity
relations are fluctuating depending on the industry. As far as startups
are concerned, it happens that many companies looking for specific
products or services that a given startup can offer. This argument has
been developed by such studies as that of Brandenburger and Nalebuff
(1996). Dushnitsky (2004) points out that there is a
complimentarily-built relation between a company and a startup and this
is likely to increase with the interest such useful startups represent
for the investing company.
On the one hand, startups develop and test technologies. On the
other hand, CVCs assist startups and gain "window" on emerging
technologies (Dushnitsky and Lenox, 2005; Wadhwa and Kotha, 2006).
Startups also facilitate the company's development through offering
additional services and significant information (Chesbrough, 2000).
Furthermore, startups can identify and monitor potential acquisition
targets (Maula and Murray, 2001).
However, Benson and Ziedonis (2010) find that CVC acquisitions tend
to destroy value for shareholders of the same acquirers. Although return
is significant and negative, there is no evidence that such a negative
reaction on the market reflects disappointment regarding the invested
payment. Hence, Benson and Ziedonis conclude that average return to CVC
acquisitions remains more than 1.5% lower than the average return to non
CVC acquisitions in multivariate analysis.
Finally, we can conclude that benefits of CVCs investments are
higher than these of independent VCs. The main explanation is their
tight commitment to startups. As opposed to independent VCs, these
benefits can be direct: value creation or indirect in their strategic
programs and their access to technologies.
In fact, investors may overpay some targets they acquire or it is
also possible that weakly-managed firms make value-destroying takeovers
of portfolio companies, which means, as Jensen (1986) shows, that
value-destruction is tightly associated to agency problems and
misaligned incentives. Another possible explanation, in Roll's
analysis (1986) as "hubris", or in Malmendier and Tate's
terms (2005) and (2008) as "over confidence" is that
destructing CVC acquisitions is the product of some biases among
managers in valuing portfolio companies. Nevertheless, these findings
turn to be unimportant empirically.
IV. CONCLUSION
In the previous analysis, we noticed that there are real advantages
for CVCs financing. The big enterprises benefit from an opportunity of
investment in a diversified portfolio, which makes it possible to reduce
the risk of innovation while keeping a certain control over startup or
an option of repurchase on the innovation once it has gone beyond the
stage of emergence.
Thus, CVC seems a more efficient way of financing to help startups
in their development.
Its current problems are due to the economic conjuncture and do not
call into question this model of financing. Moreover, it continues to
develop in the high-tech sector, which is less affected by the current
crisis, in particular the biotechnology sector. The advantages that CVC
brings to each stage of the project, as compared to venture capital
financing, will be determining factors for its future development.
REFERENCES
Artus, P., 2008, "Private Equity: un succes transitoire du a
l'environnement ou un succes durable?" in Private equity et
capitalisme frangais, Conseil d'analyse economique n[degrees]75,
300 p.
Artus, P., and J. Telletche, 2004, "Asset Allocation and
European Private Equity: A First Approach Using Aggregated Data" in
Performance Measurement and Asset Allocation for European Private Equity
Funds, EVCA Research Paper.
Arrow, K., 1974, The Limits of Organization, Norton, New York.
Ben Haj Youssef A., 2001, "Le Corporate Venture Capital: le
capital risque entrepris par les societes non financieres," Caen
Innovation Marche Entreprise, Working Paper, n 11.
Benson, D., and R. Ziedonis, 2010, "Corporate Venture Capital
and the Returns to Acquiring Portfolio Companies," Journal of
Financial Economics, 478-499.
Block, Z., and I. MacMillan, 1993, Corporate Venturing: Creating
New Business within the Firm, Harvard Business School Press, Boston, MA.
Bottazzi, L., M. DaRin, and T. Hellmann, 2004, "The Changing
Face of the European Venture Capital Industry: Facts and Analysis,"
Journal of Private Equity, 7 (2), 26-53 (Spring).
Brandenburger, A., and B. Nalebuff, 1996, Co-opetition, Harvard
Business Press.
Chesbrough, H., 2000, "Designing Corporate Ventures in the
Shadow of Private Venture Capital," California Management Review,
42 (3), 31-49.
Daft, R.L., and R. Lengel, 1986, "Organizational Information
Requirements, Media Richness, and Structural Design," Management
Science, 32(5), 554-571.
Dushnitsky, G., 2004, Limitations to Inter-organizational Knowledge
Acquisition: The Paradox of Corporate Venture Capital. Best Paper
Proceedings of the 2004 Academy of Management Conference.
Dushnitsky, G., and M.J., Lenox, 2005, "When Do Firms
Undertake R&D by Investing in New Ventures?", Strategic
Management Journal, 26 (10), 947-965.
Fuller, K., Netter, J., and M. Stegemoller, 2002, "What Do
Returns to Acquiring Firms Tell Us? Evidence from Firms that Make Many
Acquisitions" Journal of Finance 57, 1763-1793.
Ginsberg, A., I. Hassan, and C. Tucci, 2003, Unpacking the
Endorsement Effects of Corporate Venture Capital Investing: Do Equity
Markets Value Information or Discipline? Mimeo, Stern School of
Business.
Gompers, PA., and J. Lerner, 2000, "The Determinants of
Corporate Venture Capital Success, "in R. Morck (editor),
Concentrated Corporate Ownership, University of Chicago Press, pp.
17-50.
Hellman, T., 2001, "Venture Capitalists: The Coaches of
Silicon Valley." In Miller, W., C.M. Lee, M. Hanock, and H. Rowen
(eds). The Silicon Valley: A Habitat for Innovation and
Entrepreneurship, Stanford University Press.
Higgins, M., and D. Rodriguez, 2006, "The Outsourcing of
R&D through Acquisitions in the Pharmaceutical Industry,"
Journal of Financial Economics, 80, 351-383.
Hoetker, G., and R. Agarwal, 2004, Death Hurts, but It Isn't
Fatal: The Post-exit Diffusion of Knowledge Created by Innovative
Companies, Mimeo, University of Illinois, Urbana-Champaign.
Ivanov, V., and F. Xie, 2010, "Do Corporate Venture
Capitalists Add Value to Startup Firms? Evidence from IPOs and
Acquisitions of VC-Backed Companies" Financial Management, 39(1),
129-152.
Jensen, Michael C., 1986, "Agency Cost of Free Cash Flow,
Corporate Finance, and Takeovers," American Economic Review, 76
(2).
Kaplan, S. N., and A. Schoar, 2005, "Private Equity
Performance: Returns, Persistence and Capital Flows," Journal of
Finance, 60(4).
Lerner J., A. Schoar, and W. Wong, 2007, "Smart Institutions,
Foolish Choices?: The Limited Partner Performance Puzzle," Journal
of Finance, 62, 731-764.
Ljungqvist A., and M. Richardson, 2003, "The Cash Flow, Return
and Risk Characteristics of Private Equity," NBER Working Paper
9454.
Malmendier, U., and G. Tate, 2005, "CEO Overconfidence and
Corporate Investment," Journal of Finance, 60, 2661-2700.
Malmendier, U., and G. Tate, 2008, "Who Makes Acquisitions?
CEO Overconfidence and the Market's Reaction," Journal of
Financial Economics, 89, 20-43.
Maruca, R.F., 1999, "Can Big Companies Nurture Little
Companies," Harvard Business Review, Mai-Juin, 16-17.
Maula, M., and G. Murray, 2001, "Corporate Venture Capital and
the Creation of US Public Companies," Presented at the 20th Annual
Conference of the Strategic Management Society.
McGrath, A., 1999, "Falling Forward: Real Options Reasoning
and Entrepreneurial Failure." Academy of Management Review, 24 (1),
13-30.
McNally, K., 1997, Corporate Venture Capital: Bridging the Equity
Gap in the Small Business Sector. London: Routledge.
Moeller, S.B., F.P. Schlingemann, and R.M. Stulz, 2004, "Firm
Size and the Gains from Acquisitions," Journal of Financial
Economics, 73, 201-228.
Muzyka, D., S. Birley, and B. Leleux, 1996, "Trade-offs in the
Investment Decisions of European Venture Capitalists," Journal of
Business Venturing, 11(4), 273-287.
Roll, R., 1986, "The Hubris Hypothesis of Corporate
Takeovers," Journal of Business, 59, 197-216.
Stuart, T.E., H. Hoang, and R.C. Hybels, 1999,
"Interorganizational Endorsements and the Performance of
Entrepreneurial Ventures," Administrative Science Quarterly, 44,
315-349.
Teece, D.J., 1986, "Profiting from Technological Innovation:
Implications for Integration, Collaboration, Licensing and Public
policy," Research Policy, 15, 285-305.
Wadhwa, A., and S. Kotha, 2006, "Knowledge Creation through
External Venturing: Evidence from the Telecommunications Equipment
Manufacturing Industry," Academy of Management Journal, 49,
819-835.
ENDNOTE
(1). http://www.nvca.
org/index.php?option=com_content&view=article&id=
137&Itemid=216
Jean-Sebastien Lantz (a), Jean-Michel Sahut (b), Frederic Teulon
(c)
(a) Associate Professor, CEROG-CERGAM, IAEAix en Provence, France
jean-sebastien. lantz@iae-aix. com
(b) Professor, Geneva School of Business Administration,
Switzerland & CEREGE EA 1722, University of Poitiers, France
jmsahut@gmail.com
(c) Director of IPAG Lab, France f.teulon@ipag.fr
Table 1
Firms with a CVC fund structure per sector
Sector Proportion of companies
with a CVC fund
Telecommunications 80%
Semiconductors 75%
Technological equipment suppliers 71%
Software 67%
Biotechnology 62%
Aerospace 56%
Chemistry 50%
Construction 50%
Oil 40%
Communication 40%
Materials 40%
Automobile 38%
Personal products 33%
Health services 33%
Agronomy 31%
Energy 29%
Equipment 25%
Table 2
Top sectors for all venture and CVC investment
Rank for all
All Venture Venture
Industry sector Investment Investment
Software 19,5% 1
Biotechnology 17,6% 2
Medical Devices and Equipment 10,4% 3
Telecommunications 10,2% 4
Semiconductors 7,8% 5
Industrial/Energy 6,9% 6
Media and Entertainment 6,4% 7
Rank for
CVC
Industry sector CVC Investment Investment
Software 13,4% 2
Biotechnology 22,0% 1
Medical Devices and Equipment 8,6% 6
Telecommunications 12,0% 3
Semiconductors 10,5% 4
Industrial/Energy 5,3% 7
Media and Entertainment 10,1% 5
Source : National Venture Capital association, US, 2008
Table 3
Typology of corporate venture capital
Type of CVC Type of Level of Objectives of the
commitment commitment investment
1) Direct Corporate Venture Capital
1.1) Internal Financial & High To create a structure
division of Organisational dedicated to venture
venture capital capital investments to
investments try out peripheral
technologies outside
the firm.
1.2) Internal Financial & Medium or To invest, with other
investment fund Organisational High public and/or private
funds to generate both
financial returns and
have a window on new
technology.
1.3) Spinoff Financial & Medium or To promote -
Venture Organisational High externally--the
development of by-
products using the
company's internal
expertise.
1.4) Venture Financial & Medium Association of a
cooperation Organisational corporation and an
innovative SME to
develop a joint
project.
1.5) With Financial Low Occasional investment
step-by-step' with weak decisional
investment and technological
control in
collaboration with
other investors.
2) Indirect Corporate Venture Capital
External Financial Medium or Make financial returns
Investment fund High from investments in
various innovative SME
portfolios via a
Venture Capital Firm.
Source: Adapted from Ben Haj Youssef (2001)
Table 4
What are the objectives of CVC investors?
Provide window on new market 92%
Develop new products 88%
Gain window on emerging technologies 83%
Explore new directions 77%
Support existing businesses 65%
Improve manufacturing processes 58%
Table 5
Benefits of a "corporate venture capitalist" to the start-up
Benefits from a CVC investment Mentioned %
Help for short-term problems 19 83%
Access to expertise in company management 16 70%
Giving credibility to the startup 16 70%
Access to technical expertise 11 48%
Price advantages on some resources 10 43%
Performance goals which are less restricting 9 39%
than a venture capital fund
Access to the company's marketing/ 9 39%
distribution networks
R&D and production support 8 35%
Starting point for other relationships 1 4%
with the company
Access to more sophisticated means of 1 4%
financial control
Supply of space, offices 1 4%
Access to more openings for the startup 1 4%
Synergies 1 4%
Added attractiveness vis-a-vis other investors 1 4%
Stability 1 4%
Access to the company's operational expertise 1 4%